CILIATECH trademark application published for opposition
Summary
The USPTO has published the trademark application for CILIATECH, which covers a range of goods and services related to ophthalmology, including medical research, prostheses, implants, and pharmaceutical products. The application was published for opposition on March 26, 2026.
What changed
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'CILIATECH' (TM79436415) for opposition. The application covers a broad scope of goods and services primarily focused on ophthalmology, including medical and scientific research, design and development of prostheses and medical technologies, clinical trials, biological and pharmaceutical products for ophthalmic use, and various ophthalmic instruments and devices.
This publication initiates a period during which third parties may oppose the trademark registration. Companies operating in the ophthalmology sector, particularly those involved in research, development, manufacturing of pharmaceuticals, medical devices, or prostheses, should review the application details. While this is a trademark publication and not a regulatory rule, it signifies a potential new market entrant or product line that could impact existing market players and intellectual property considerations.
What to do next
- Review trademark application TM79436415 for CILIATECH for potential conflicts or opposition.
- Monitor the opposition period for the CILIATECH trademark application.
Source document (simplified)
← USPTO Trademark Applications
CILIATECH
Published for Opposition TM79436415 Kind: published Mar 26, 2026
Abstract
Providing medical and scientific research information in the field of ophthalmology; design of prostheses; development of prostheses; Scientific research in clinical surgery; scientific research for medical purposes; design and development of medical technologies; analysis of human tissues for medical research; Clinical research in the field of ophthalmology; Materials testing; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Scientific research in the nature of conducting clinical trials for others in the field of ophthalmology; basic and clinical research with respect to ophthalmology; design and development of technology with respect to ophthalmology; Medical research and development of new products.; Biological implants namely, a vital processed human or animal connective tissue, for use in ophthalmology; implants comprising living human or animal tissue for use in ophthalmology; pharmaceutical products for ophthalmological use; Pharmaceutical preparations in the nature of implantable medicines for use in ophthalmology ; Implantable textile material comprising primarily of living tissue to facilitate tissue growth for use in ophthalmology; Medicated eye lotions for medical use; Medicated lubrication eye ointment for medical use.; Publication of manuals; publication of documents; provision of non-downloadable electronic publications online; publication of medical texts; publication of scientific articles; editing of medical publications; Writing of articles for journals other than for advertising or publicity; publication of scientific articles relating to medical technology; publication of medical articles in the field of surgery; publication of clinical trial results in the field of surgery.; Custom manufacture of prostheses.; Prostheses for eyes; Prostheses implants consisting primarily of artificial materials and biological materials; Prostheses for surgical treatment for eyes; prostheses for medical use for eyes; Medical devices, instruments and apparatus for the implantation of ophthalmic artificial prostheses; all these goods for use in ophthalmology; ocular implants made of artificial materials; Intraocular implants made of artificial materials; Intraocular prostheses, namely, lenses for surgical implantation; Implants consisting of artificial materials for the use in ophthalmological prostheses surgery; Ophthalmological instruments, namely, surgical instruments for intraocular implant which purpose is to deliver the implant in or close to its final location, in particular forceps, tweezers, injector syringes, injection systems comprising injector syringes or cartridges adapted to contain intraocular implants; therapeutic instruments for ophthalmology; instruments for diagnosis in ophthalmology.
Filing Date
2025-04-22
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.